ArticleTherapeutics and clinical risk management2009

Casopitant: a novel NK(1)-receptor antagonist in the prevention of chemotherapy-induced nausea and vomiting.

Christina Ruhlmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.